GlassScriptPhysician profile
Emily B Boyd
NPI 1730257924
$8,964.84
in general payments reported to CMS, 2019-2025
31 companies · $401 in 2025
The $401 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $47.67 · 2021: $1,138 · 2022: $505 · 2023: $5,645 · 2024: $726 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $2,131 · Travel and Lodging: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $2,130.92 |
| Travel and Lodging | $641.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,157.94 | 2019-2024 | Da Vinci Surgical System |
| Abbvie INC. | $343.15 | 2019-2025 | Vraylar, Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $297.51 | 2023-2025 | Myfembree |
| Organon LLC | $281.37 | 2022-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $186.23 | 2022-2025 | |
| Endomagnetics LTD | $184.12 | 2022 | |
| Novo Nordisk INC | $167.85 | 2022-2024 | Wegovy |
| Hologic Sales and Service, LLC | $150.01 | 2022-2025 | Third Wave, Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $144.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.04 | 2019-2025 | |
| Sage Therapeutics, LLC | $109.88 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $108.05 | 2023-2025 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $104.84 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $94.90 | 2022-2025 | Slynd |
| Baxter Healthcare | $91.38 | 2019-2024 | Perclot |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $47.67 | 2022 | |
| Dexcom, INC. | $43.28 | 2024-2025 | Dexcom G6 Transmitter |
| Avanos Medical | $36.92 | 2023-2024 | On-Q* Pump and Accessories |
| Millicent US INC | $36.88 | 2025 | Femlyv |
| Mylan Pharmaceuticals INC. | $34.23 | 2022 | |
| Meditrina | $34.09 | 2023-2025 | |
| Aspira Women'S Health INC | $32.95 | 2024 | Ova1 |
| Exact Sciences Corporation | $24.62 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $22.62 | 2019-2020 | |
| Genzyme Corporation | $20.67 | 2025 | |
| Agile Therapeutics, INC. | $17.36 | 2023 | Twirla |
| Lilly USA, LLC | $17.17 | 2024 | Zepbound |
| Viiv Healthcare Company | $15.70 | 2022 | |
| Coopersurgical, INC. | $14.06 | 2023 | Wallach Cryosurgical Equipment |
| Smith+Nephew, INC. | $13.81 | 2022 | |
| Duchesnay USA Incorporated | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.